News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Singular Health Group.
RELATED STOCKHEAD STORIES
Health & Biotech
Singular Health’s 3Dicom FDA submission could open door to US$885.2m medical imaging software market
News
Rise and Shine: Everything you need to know before the ASX opens
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Leading Aussie medtechs Osteopore and Singular Health reveal landmark deal
News
Closing Bell: Resources reboot puts fresh socks on small cap index
News
Closing Bell: Sinking local markets jump ship as Central Bank prepares to board
Health & Biotech
Singular’s additive manufacturing investment is bearing fruit
Health & Biotech
Singular’s AI-based cranial implant gets a partner to dream of in Osteopore
Health & Biotech
ASX Health Stocks: US FDA approval could expand EBR Systems’ addressable market by $400m
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
Singular enters giant East Asia medical VR market with breakthrough Macau JV
Health & Biotech
Government backs Singular Health innovation with $305k R&D tax fund
Health & Biotech
RedLeaf: Singular has a sweet slice of the global VR, AI medical imaging pie
Experts
MoneyTalks: VFS Groups’ James Whelan is bullish on Metaverse stocks. Here’s why
Health & Biotech
Singular charges into 2022 with a new research grant, and the first customer signup for its 3Dicom Surface technology
Health & Biotech
ASX Health Stocks: Emyria to create wearable device for psychedelics, while Telix gets FDA nod
Health & Biotech